Vaxcyte Inc (PCVX) Is A Hidden Multibagger Stock To Buy Now
Key takeaways
- Vaxcyte Inc (PCVX) Is A Hidden Multibagger Stock To Buy Now Jabran Kundi Fri, July 3, 2026 at 8:41 PM GMT+7 2 min read PCVX Vaxcyte Inc.
- Earlier on June 16, PCVX announced an update regarding its ongoing clinical study.
- If the trial shows positive results, the vaccine could allow the company to enter a new market for preventing Group A strep infections.
Vaxcyte Inc (PCVX) Is A Hidden Multibagger Stock To Buy Now Jabran Kundi Fri, July 3, 2026 at 8:41 PM GMT+7 2 min read PCVX Vaxcyte Inc. (NASDAQ:PCVX) is one of the 8 Hidden Multibagger Stocks to Buy Now. On June 18, Mizuho Securities analyst Salim Syed reiterated a Buy rating on Vaxcyte Inc. (NASDAQ:PCVX) with a price target of $163. The firm's price target reflects a significant 180% upside from current levels.
Earlier on June 16, PCVX announced an update regarding its ongoing clinical study. The company is conducting an early-stage clinical trial of VAX-A1, a vaccine designed to protect against Group A strep infections. The study will evaluate the safety, tolerability, and immunogenicity of VAX-A1 in healthy young adults. The trial is testing three different dose levels of the vaccine against a placebo. It is administered via muscle injection and is designed to support the immune system.
If the trial shows positive results, the vaccine could allow the company to enter a new market for preventing Group A strep infections. This could boost investor confidence in the company and support the stock's valuation. However, disappointing results could increase concerns about the program and shift attention toward larger vaccine competitors such as Pfizer and GSK.